- Boxlight reports Q3 roughly in line with guidance and issues a less-than-stellar outlook for Q4. Initial FY2022 projections also fail to impress.
- According to management, business momentum remains strong and guidance should be viewed as conservative.
- Company needs to arrange an aggregate $50 million in short-term financing to redeem its Series B Preferred Stock and pay for the recent acquisition of FrontRow Calypso.
- Another toxic convertible notes issuance to the company's primary lender, Lind Global Asset Management, appears to be the most likely outcome with the very real potential for further, substantial dilution.
- While shares remain cheap, I am not looking to buy the dip and rather prefer waiting for the ultimate financing terms to be released.
For further details see:
Boxlight Corp.: Uninspiring Quarter And Outlook Cause Shares To Sell Off